Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.830
+0.020 (0.71%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Nkarta Market Cap
Nkarta has a market cap or net worth of $202.7 million as of September 18, 2026. Its market cap has increased by 49.42% in one year.
Market Cap
202.70M
Enterprise Value
93.47M
1-Year Change
49.42%
Ranking
Category
Stock Price
$2.83
ChartMarket Cap Chart
Since July 10, 2020, Nkarta's market cap has decreased from $1.46B to $202.70M, a decrease of -86.16%. That is a compound annual growth rate of -27.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 202.70M | 54.26% |
| Dec 31, 2025 | 131.40M | -25.22% |
| Dec 31, 2024 | 175.72M | -45.75% |
| Dec 29, 2023 | 323.88M | 10.77% |
| Dec 30, 2022 | 292.39M | -42.19% |
| Dec 31, 2021 | 505.77M | -74.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alector | 213.26M |
| Eledon Pharmaceuticals | 213.11M |
| Protara Therapeutics | 209.79M |
| Coherus Oncology | 208.58M |
| Veraxa Biotech AG | 206.46M |
| PepGen | 197.39M |
| Satellos Bioscience | 197.34M |
| Oramed Pharmaceuticals | 197.17M |